ArticleGlobal epidemiology2025
Epidemiological and histopathological profile of lung Cancer: Insights from a 15-year cross-sectional study at a tertiary care centre in South India.
Article in Global epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Past, present and future of nivolumab: new horizons in immuno-oncology.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background In India, lung cancer accounts for 5.9 % of all cancers and 8.1 % of all cancer-related deaths, with adenocarcinoma emerging as the most common histopathological subtype in developing countries. Aims To analyze the shifting trends in the epidemiology and histopathology of lung cancer over 15 years, with a focus on gender differences in the prevalence of adenocarcinoma. Method This observational, cross-sectional study was conducted at a tertiary care center in Southern India to evaluate the trends in the epidemiology and histopathology of lung cancer over a 15-year period (2008-2022). Data were gathered from patients aged ≥18 diagnosed with primary lung carcinoma. The annual distribution of patients was documented based on age, sex, and tumor histopathology. The analysis was conducted using SPSS software. Results A total of 4466 newly diagnosed primary lung cancer cases were analyzed over a 15-year period. The median age at diagnosis was 64 years, with a shift in age distribution over time. The proportion of female cases rose from 20.1 % to 28.4 %, while male cases declined from 79 % to 71 %, indicating a significant gender shift. Adenocarcinoma was the most common histopathology subtype, increasing from 22 % to 40 % in men and from 32 % to 55 % in women. Significant associations were observed between histopathology subtype and age group, gender, and year of diagnosis. Conclusion The study revealed evolving trends in the lung cancer profile over the last 15 years. A significant increase in the prevalence of adenocarcinoma was observed, with a more pronounced rise among women compared to men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.